These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2159814)

  • 1. [Study of xanthine oxidase activity in the brain tissue after administration of dalargin during myoplegia].
    Korotkina RN; Shloznikov BM; Donich SG; Grebenchikov OA; Sitnikov AV; Karelin AA
    Biull Eksp Biol Med; 1990 Feb; 109(2):145-6. PubMed ID: 2159814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The antinociceptive properties of dalargin as an agent of anesthesiologic protection].
    Shloznikov BM; Donich SG; Grebenchikova OA; Makhmutov RF; Likhvantsev VV; Kuznetsov AIu; Peretrukin AI; Fomchenkov EP
    Biull Eksp Biol Med; 1990 Mar; 109(3):272-5. PubMed ID: 2163692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations made during operations performed under Arduan relaxation.
    Horváth I; Illés T
    Ther Hung; 1984; 32(1):13-5. PubMed ID: 6100828
    [No Abstract]   [Full Text] [Related]  

  • 5. Oto-rhino-laryngological interventions performed in arduan relaxation.
    Zelen B
    Ther Hung; 1985; 33(4):211-3. PubMed ID: 3020731
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the neuromuscular blocking effect of Arduan.
    Tassonyi E
    Ther Hung; 1983; 31(1):13-7. PubMed ID: 6100820
    [No Abstract]   [Full Text] [Related]  

  • 7. More information about pipecurium, a new neuromuscular blocking agent.
    Boros M
    Anesthesiology; 1983 Jan; 58(1):108. PubMed ID: 6293346
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical, electromyographic and electromechanographic studies of the nondepolarizing muscle relaxant pipecurium bromide (Arduan)].
    Stoianov E; Shtŭrbova M; Marinova M
    Khirurgiia (Sofiia); 1988; 41(5):35-7. PubMed ID: 2851068
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations on the neuromuscular blocking action of pipecuronium in the dog.
    Jones RS
    Res Vet Sci; 1987 Jul; 43(1):101-3. PubMed ID: 2820005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of pipecuronium bromide.
    Larijani GE; Bartkowski RR; Azad SS; Seltzer JL; Weinberger MJ; Beach CA; Goldberg ME
    Anesth Analg; 1989 Jun; 68(6):734-9. PubMed ID: 2544118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between pipecuronium and suxamethonium in the dog.
    Jones RS
    Res Vet Sci; 1987 Nov; 43(3):308-12. PubMed ID: 2832912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of several regulatory peptides on the functional activity of the pancreas in acute experimental pancreatitis].
    Grigorevskiĭ VP; Korotkina RN; Karelin AA
    Biull Eksp Biol Med; 1989 Oct; 108(10):428-30. PubMed ID: 2597753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Naguib M; Abdulatif M
    Can J Anaesth; 1991 Sep; 38(6):722-7. PubMed ID: 1655299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, isoflurane, and halothane anesthesia in adults and children.
    Pittet JF; Tassonyi E; Morel DR; Gemperle G; Richter M; Rouge JC
    Anesthesiology; 1989 Aug; 71(2):210-3. PubMed ID: 2547325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pipecuronium and pancuronium on the isolated rabbit heart.
    Deam RK; Soni N
    Br J Anaesth; 1989 Mar; 62(3):287-9. PubMed ID: 2564784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of a new neuromuscular blocking agent, pipecuronium bromide (Arduan)].
    Tuba Z; Mahó S
    Acta Pharm Hung; 1992 May; 62(3):73-81. PubMed ID: 1323916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulatory effects of pipecurium bromide during anaesthesia of patients with severe valvular and ischaemic heart diseases.
    Barankay A
    Arzneimittelforschung; 1980; 30(2a):386-9. PubMed ID: 6248086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.
    Wierda JM; Richardson FJ; Agoston S
    Anesth Analg; 1989 Mar; 68(3):208-13. PubMed ID: 2537588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the steroid muscle relaxant pipecurium bromide on the acetylcholinesterase activity of red blood cells in vitro.
    Simon G; Biró K; Kárpáti E; Tuba Z
    Arzneimittelforschung; 1980; 30(2a):360-3. PubMed ID: 6248079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.